Similar live GeM bids
HomeGeM BidsMedical EquipmentGEM/2026/R/686922
Medical EquipmentGoodsDefenceWorksReverse Auction

Procurement of various pharmaceutical tablets including Acebrophylline, Alfuzosin, Dutasteride, and Amantadine for the Indian Army

Indian Army invited bids on GeM for "Procurement of various pharmaceutical tablets including Acebrophylline, Alfuzosin, Dutasteride, and Amantadine for the Indian Army" — a Medical Equipment works procurement via reverse auction. Bids close on 26 Jun 2026, 15:30. Quantity 194522. Bid number GEM/2026/R/686922.
Ministry of Defence » Department of Military Affairs » Indian Army · Bid GEM/2026/R/686922
Est. value
Not disclosed
Bid closes
26 Jun 2026
3 days left
Quantity
194522
Status
Closing soon

Bid document

Bid details are referenced from GeM (bidplus.gem.gov.in). Live bidding and authoritative documents remain on the official portal.

Complete bid details

Buyer & organisation
Ministry / StateMinistry of Defence
DepartmentDepartment of Military Affairs
OrganisationIndian Army
SectorDefence
Buyer typeCentral
Item & category
ItemACEBROPHYLLINE 200 MG SR,ALFUZOSIN 10 MG plus DUTASTERIDE 0 point 5 MG TAB,AMANTADINE 100MG TAB,BRI
CategoryMedical Equipment
Sub-categoryPharmaceuticals
TypeGoods
ProcurementWorks
Quantity194522
Reverse AuctionYes
Make-in-India pref.Yes
BiddingTwo-packet
Financials & eligibility
Estimated valueNot disclosed
Value tierNot disclosed
EMD requiredYes
ePBG requiredYes
MSE-friendlyYes
Startup-friendlyYes
New-seller-friendlyYes
Installation req.No
Inspection req.No
CertificationsIS code
Delivery
Delivery statesRajasthan
ScopeSingle-state

Frequently asked questions

What is this GeM bid for?
Indian Army floated this GeM bid for "Procurement of various pharmaceutical tablets including Acebrophylline, Alfuzosin, Dutasteride, and Amantadine for the Indian Army" under Medical Equipment, procured as works.
What is the estimated value?
The value tier was not disclosed for this bid.
When does this bid close?
Bids close on 26 Jun 2026, 15:30.
Is it MSE / startup friendly?
MSE-friendly: Yes; Startup-friendly: Yes; New-seller-friendly: Yes.